stock offering
Checkpoint Therapeutics Announces $10M Registered Direct Offering of Common Stock
The company will use the funds to support the manufacturing and pre-commercial activities for its lead candidate cosibelimab.
UPDATE: ImmunoGen Prices $325M Public Stock Offering
The firm will use the proceeds to support commercialization and supply for its ovarian cancer treatment Elahere and to advance its pipeline.
Ideaya Prices $175M Public Offering of Common Stock
The firm will use the proceeds to advance its pipeline of precision oncology products, including a potential registrational study of its lead candidate darovasertib in uveal melanoma.
Allarity Therapeutics Prices $7.5M Public Offering
The firm is offering a combination of common shares, pre-funded warrants, and common warrants at $.75 per share and common warrant.
BridgeBio Launches $150M Public Offering of Common Stock
The firm will also grant underwriters a 30-day option to purchase additional shares of its common stock valued at up to $22.5 million.
Mar 1, 2023
2seventy Bio Prices $125M Public Offering
Sep 13, 2022